Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BTBD9 anticorps (AA 200-400)

L’anticorps anti-BTBD9 Monoclonal Souris est utilisé pour la détection de BTBD9 dans des échantillons de Humain. Il a été validé pour IHC.
N° du produit ABIN7859463
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour BTBD9 anticorps (AA 200-400) (ABIN7859463)

Antigène

Voir toutes BTBD9 Anticorps
BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))

Reactivité

  • 18
  • 2
  • 1
Humain

Hôte

  • 12
  • 6
Souris

Clonalité

  • 15
  • 3
Monoclonal

Conjugué

  • 13
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BTBD9 est non-conjugé

Application

  • 16
  • 10
  • 9
  • 9
  • 2
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

BTBD9-7501
  • Épitope

    • 8
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 200-400

    Fonction

    BTBD9 Antibody

    Specificité

    BTBD9 (BTB/POZ domain-containing protein 9) is a 612 amino acid protein that contains one BTB/POZ domain and one BACK (BTB/Kelch associated) domain. The BTB/POZ domain mediates homomeric and heteromeric POZPOZ interactions and is common to transcriptional regulators involved in chromatin modeling. In several BTB/POZ containing proteins, including Bcl-6 and the promyelocytic leukemia zinc-finger (PLZF) oncoprotein, this domain interacts with the SMRT/N-CoR-mSin3A HDAC complex and is directly involved in repressing and silencing gene transcription. When this domain is deleted, as with the oncogenic PLZF-RAR chimera of promyelocytic leukemias, this transcriptional repression is attenuated. This suggests that BTBD9 may play a role in transcription regulation. Genetic variations in the gene that encodes BTBD9 have been associated with susceptibility to restless legs syndrome type 6 (RLS6), a condition characterized by an uncontrollable urge to move the legs while resting.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment (around aa200-400) of human BTBD9 protein (exact sequence is proprietary)

    Isotype

    IgG1, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))

    Autre désignation

    BTBD9

    Sujet

    BTB/POZ domain-containing protein 9

    Human fallopian tube|lung or lymph node.

    Poids moléculaire

    69kDa

    ID gène

    114781, 603858

    UniProt

    Q96Q07

    Pathways

    Transition Metal Ion Homeostasis
Vous êtes ici:
Chat with us!